April 1 (Reuters) - Tilray Inc TLRY.O :
* TILRAY INC - ANNOUNCES SUPPORT OF TWO NEW CLINICAL RESEARCH STUDIES IN AUSTRALIA AND CANADA
* TILRAY INC - ANNOUNCED SUPPORT OF CLINICAL STUDIES IN A PILOT STUDY LED BY MURDOCH CHILDREN'S RESEARCH INSTITUTE (MCRI) IN MELBOURNE
* TILRAY INC - ANNOUNCED SUPPORT OF A STUDY WITH MCGILL UNIVERSITY HEALTH CENTRE'S DIVISION OF INFECTIOUS DISEASES AND CHRONIC VIRAL ILLNESS
* TILRAY - STUDY WITH MCGILL UNIVERSITY HEALTH CENTRE TO EXAMINE EFFECTIVENESS OF MEDICAL CANNABIS ON IMMUNE ACTIVATION IN PEOPLE LIVING WITH HIV
* TILRAY - MURDOCH CHILDREN'S RESEARCH INSTITUTE TO STUDY FEASIBILITY,ACCEPTABILITY OF CANNABIS EXTRACT AS TREATMENT FOR REDUCING SEVERE BEHAVIORAL PROBLEMS IN CHILDREN